Childs G V, Unabia G, Rougeau D
Department of Anatomy and Neuroscience, University of Texas Medical Branch, Galveston 77555.
Endocrinology. 1994 Feb;134(2):990-7. doi: 10.1210/endo.134.2.8299592.
There is a 2-fold increase in the percentage of gonadotropes bearing LH beta or FSH beta mRNAs or antigens as the cells approach proestrus. The purpose of this study was to identify the source of these cells with dual labeling techniques. The first hypothesis was that they stemmed from small monohormonal gonadotropes (containing only LH or FSH) that were driven to transcribe and translate the other gonadotropin. Alternatively, they may stem from other pituitary cell types. We detected the LH beta or FSH beta mRNAs by in situ hybridization (biotinylated oligonucleotide probes were detected by peroxidase-labeled avidin). Second, immunolabeling protocols localized the pituitary hormones. The percentages of cells with LH beta antigens and FSH beta mRNA increased to 81% of the LH beta antigen-bearing cells by the time of peak expression of FSH beta mRNA. Similarly, FSH beta antigen-bearing cells increased their expression of LH beta mRNA to 40% of such cells by the morning of proestrus. During the peak period of expression (the evening of proestrus), LH antigen-bearing cells had increased their expression of LH beta mRNA to 93%. Furthermore, 81% of the same cells expressed FSH beta mRNA. Thus, at least 80% of cells with LH antigens became bihormonal as the cells approached proestrus. This partially supports the first hypothesis for the origin of the new gonadotropes. However, the dual labeling studies also showed that 47% or 60% of cells with GH antigens expressed LH beta or FSH beta mRNAs, respectively, during peak expression (14% of pituitary cells contained gonadotropin mRNAs and GH antigens). Expression by cells with other antigens was low or absent (< 5% of pituitary cells). Perhaps a subset of somatotropes expresses gonadotropin mRNAs. Alternatively, the labeling could signify the presence of GH bound to GH receptors in gonadotropes. In either case, it appears that GH cells may be somehow linked to gonadotrope function as the cells approach proestrus.
随着细胞接近发情前期,携带促黄体生成素β(LHβ)或促卵泡生成素β(FSHβ)mRNA或抗原的促性腺激素细胞百分比增加了两倍。本研究的目的是用双重标记技术确定这些细胞的来源。第一个假设是它们起源于小型单激素促性腺激素细胞(仅含LH或FSH),这些细胞被驱动转录和翻译另一种促性腺激素。或者,它们可能起源于其他垂体细胞类型。我们通过原位杂交检测LHβ或FSHβmRNA(用辣根过氧化物酶标记的抗生物素蛋白检测生物素化的寡核苷酸探针)。其次,免疫标记方案对垂体激素进行定位。到FSHβmRNA表达峰值时,带有LHβ抗原和FSHβmRNA的细胞百分比增加到带有LHβ抗原细胞的81%。同样,到发情前期早晨,带有FSHβ抗原的细胞将其LHβmRNA表达增加到此类细胞的40%。在表达高峰期(发情前期晚上),带有LH抗原的细胞将其LHβmRNA表达增加到93%。此外,同一细胞中有81%表达FSHβmRNA。因此,随着细胞接近发情前期,至少80%带有LH抗原的细胞变成了双激素细胞。这部分支持了新促性腺激素细胞起源的第一个假设。然而,双重标记研究还表明,在表达高峰期,分别有47%或60%带有生长激素(GH)抗原的细胞表达LHβ或FSHβmRNA(14%的垂体细胞含有促性腺激素mRNA和GH抗原)。带有其他抗原的细胞表达很低或无表达(<5%的垂体细胞)。也许生长激素细胞的一个亚群表达促性腺激素mRNA。或者,这种标记可能表明促性腺激素细胞中存在与GH受体结合的GH。无论哪种情况,似乎在细胞接近发情前期时,GH细胞可能以某种方式与促性腺激素细胞功能相关联。